Iressa Drug Failure Deals AstraZeneca Fresh Blow AstraZeneca Plc suffered its third setback in two months on Friday as lung cancer drug Iressa failed to help patients live longer  
Is this a piece of news regarding world politics, sports, business, or science and technology? 